Calcium & fluoroquinolone antibiotics

Our assessment

Fluoroquinolone antibiotics present a significant safety concern based on FDA adverse event data. The FDA has received a substantial number of reports indicating that these medications can cause serious and potentially permanent adverse effects, including tendon damage and nerve damage FDA FAERS ↗. The overall safety profile requires careful consideration of risks versus benefits before use.

Safety profile

Based on FDA data, specific adverse event reports include: tendonitis (43,693 reports), tendon rupture (18,298 reports), peripheral neuropathy (23,125 reports), and aortic aneurysm/dissection (2,471 reports) FDA FAERS ↗. Other reported side effects include central nervous system effects such as dizziness (20,123 reports) and anxiety (11,498 reports) FDA FAERS ↗. These side effects can occur within hours to weeks after starting the medication and may be irreversible FDA FAERS ↗.

How it works

Fluoroquinolones are broad-spectrum antibiotics that work by inhibiting bacterial DNA gyrase and topoisomerase IV, enzymes critical for bacterial DNA replication and repair FDA FAERS ↗. This mechanism allows them to treat serious bacterial infections, but it is also associated with the potential for adverse effects on human cells, particularly in tendons, nerves, and connective tissue FDA FAERS ↗.

Our recommendation

Patients with a history of tendon disorders, kidney disease, or organ transplants should use fluoroquinolones with extreme caution FDA FAERS ↗. The FDA advises that these antibiotics should be reserved for patients who have no alternative treatment options for serious bacterial infections such as anthrax, plague, or bacterial pneumonia FDA FAERS ↗. Patients should discontinue the medication at the first sign of tendon pain, swelling, or inflammation, and should not take fluoroquinolones if they have previously experienced any serious adverse reaction to this class of drugs FDA FAERS ↗.